Clinical Trial

Preoperative Biliary Drainage in Malignant Biliary Obstruction

Study acronym: PEAR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 19, 2021 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The first alarming symptom of a malignancy of the pancreas or periampullary tumor can be obstructive jaundice (OJ). Pancreato-duodenectomy (PD) combined with oncological treatment can provide long disease-free survival in resectable cases. The literature regarding the preoperative biliary drainage is controversial. The aim of this multicenter, prospective observational cohort study is to investigate the role of preoperative drainage, and to compare it with surgery alone.
Trial Details
NCT Number NCT04847297
Lead Sponsor University of Pecs
Conditions Pancreatic Cancer
Enrollment 353 participants
Start Date 2021-09-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-04-19